| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |